Liposome Drug Delivery Market Report

China Liposome Drug Delivery Industry Market Research Report 2023-2029

  • POSTDATE：Sep 28, 2023
  • PAGES：215
  • REPORT CODE：GMM1817199
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Liposomes is defined as the small spherical-shaped artificial vesicles, which are synthesized from phospholipids and cholesterol. It is colloidal carriers as well as a range from 0.01 to 5.0 μm in diameter. It is widely used to improve the therapeutic index of established drugs by reducing metabolism and reducing toxicity.

    This report elaborates on the current development of the Liposome Drug Delivery industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Spectrum Pharmaceuticals

    • Teva Pharmaceutical

    • Sun Pharmaceutical

    • Kingond Pharm

    • CSPC

    • Fudan-Zhangjiang

    • Johnson and Johnson

    • Sigma-Tau Group

    • Shanghai New Asia

    • Luye Pharma

    • Gilead Sciences

    • Pacira

    By Type:

    • Liposomal Doxorubicin

    • Other Liposomals

    • Liposomal Paclitaxel

    • Liposomal Bupivacaine

    • Liposomal Amphoteracin B

    By Application:

    • Fungal Infection Therapy

    • Cancer and Tumor Therapy

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Liposome Drug Delivery Market Overview 2018-2029

    • 1.1 China Liposome Drug Delivery Industry Development Overview

    • 1.2 China Liposome Drug Delivery Industry Development History

    • 1.3 China Liposome Drug Delivery Industry Market Size (2018-2029)

    • 1.4 China Liposome Drug Delivery Market Analysis by Type from Production Side

      • 1.4.1 China Liposome Drug Delivery Production Volume, Production Value and Growth Rate of Liposomal Doxorubicin (2018-2029)

      • 1.4.2 China Liposome Drug Delivery Production Volume, Production Value and Growth Rate of Other Liposomals (2018-2029)

      • 1.4.3 China Liposome Drug Delivery Production Volume, Production Value and Growth Rate of Liposomal Paclitaxel (2018-2029)

      • 1.4.4 China Liposome Drug Delivery Production Volume, Production Value and Growth Rate of Liposomal Bupivacaine (2018-2029)

      • 1.4.5 China Liposome Drug Delivery Production Volume, Production Value and Growth Rate of Liposomal Amphoteracin B (2018-2029)

    • 1.5 China Liposome Drug Delivery Market Analysis by Application from Consumption End

      • 1.5.1 China Liposome Drug Delivery Sales Volume, Sales Value and Growth Rate of Fungal Infection Therapy (2018-2029)

      • 1.5.2 China Liposome Drug Delivery Sales Volume, Sales Value and Growth Rate of Cancer and Tumor Therapy (2018-2029)

      • 1.5.3 China Liposome Drug Delivery Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Liposome Drug Delivery Market Analysis by Region

      • 1.6.1 North China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

    Chapter 2 China Liposome Drug Delivery Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Liposome Drug Delivery Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Liposome Drug Delivery Market Status and Competition Analysis in 2023

      • 2.2.3 China Liposome Drug Delivery Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Liposome Drug Delivery Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Liposome Drug Delivery Industry Development

    Chapter 3 Liposome Drug DeliveryIndustry Chain Analysis

    • 3.1 Liposome Drug Delivery Industry Chain

    • 3.2 Liposome Drug Delivery Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Liposome Drug Delivery Market

    • 3.3 Liposome Drug Delivery Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Liposome Drug Delivery Market

    Chapter 4 China Liposome Drug Delivery Market, by Type

    • 4.1 China Liposome Drug Delivery Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Liposome Drug Delivery Total Production Volume and Growth Rate from Production Side

    • 4.5 China Liposome Drug Delivery Production Volume and Growth Rate, by Type

      • 4.5.1 China Liposome Drug Delivery Production Volume and Growth Rate of Liposomal Doxorubicin

      • 4.5.2 China Liposome Drug Delivery Production Volume and Growth Rate of Other Liposomals

      • 4.5.3 China Liposome Drug Delivery Production Volume and Growth Rate of Liposomal Paclitaxel

      • 4.5.4 China Liposome Drug Delivery Production Volume and Growth Rate of Liposomal Bupivacaine

      • 4.5.5 China Liposome Drug Delivery Production Volume and Growth Rate of Liposomal Amphoteracin B

    Chapter 5 China Liposome Drug Delivery Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Liposome Drug Delivery Total Market Size and Growth Rate from Consumption End

    • 5.5 China Liposome Drug Delivery Market Size and Growth Rate, by Application

      • 5.5.1 China Liposome Drug Delivery Market Size and Growth Rate of Fungal Infection Therapy

      • 5.5.2 China Liposome Drug Delivery Market Size and Growth Rate of Cancer and Tumor Therapy

      • 5.5.3 China Liposome Drug Delivery Market Size and Growth Rate of Others

    Chapter 6 China Liposome Drug Delivery Market, by Region

    • 6.1 China Liposome Drug Delivery Production Volume and Production Value, by Region

    • 6.2 China Liposome Drug Delivery Sales Volume and Sales Value, by Region

    Chapter 7 North China Liposome Drug Delivery Market Analysis

    • 7.1 North China Liposome Drug Delivery Market, by Type

    • 7.2 North China Liposome Drug Delivery Market, by Application

    Chapter 8 Central China Liposome Drug Delivery Market Analysis

    • 8.1 Central China Liposome Drug Delivery Market, by Type

    • 8.2 Central China Liposome Drug Delivery Market, by Application

    Chapter 9 South China Liposome Drug Delivery Market Analysis

    • 9.1 South China Liposome Drug Delivery Market, by Type

    • 9.2 South China Liposome Drug Delivery Market, by Application

    Chapter 10 East China Liposome Drug Delivery Market Analysis

    • 10.1 East China Liposome Drug Delivery Market, by Type

    • 10.2 East China Liposome Drug Delivery Market, by Application

    Chapter 11 Northeast China Liposome Drug Delivery Market Analysis

    • 11.1 Northeast China Liposome Drug Delivery Market, by Type

    • 11.2 Northeast China Liposome Drug Delivery Market, by Application

    Chapter 12 Southwest China Liposome Drug Delivery Market Analysis

    • 12.1 Southwest China Liposome Drug Delivery Market, by Type

    • 12.2 Southwest China Liposome Drug Delivery Market, by Application

    Chapter 13 Northwest China Liposome Drug Delivery Market Analysis

    • 13.1 Northwest China Liposome Drug Delivery Market, by Type

    • 13.2 Northwest China Liposome Drug Delivery Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Spectrum Pharmaceuticals

        • 14.1.1 Spectrum Pharmaceuticals Company Profile

        • 14.1.2 Spectrum Pharmaceuticals Liposome Drug Delivery Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Teva Pharmaceutical

        • 14.2.1 Teva Pharmaceutical Company Profile

        • 14.2.2 Teva Pharmaceutical Liposome Drug Delivery Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Sun Pharmaceutical

        • 14.3.1 Sun Pharmaceutical Company Profile

        • 14.3.2 Sun Pharmaceutical Liposome Drug Delivery Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Kingond Pharm

        • 14.4.1 Kingond Pharm Company Profile

        • 14.4.2 Kingond Pharm Liposome Drug Delivery Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 CSPC

        • 14.5.1 CSPC Company Profile

        • 14.5.2 CSPC Liposome Drug Delivery Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Fudan-Zhangjiang

        • 14.6.1 Fudan-Zhangjiang Company Profile

        • 14.6.2 Fudan-Zhangjiang Liposome Drug Delivery Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Johnson and Johnson

        • 14.7.1 Johnson and Johnson Company Profile

        • 14.7.2 Johnson and Johnson Liposome Drug Delivery Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Sigma-Tau Group

        • 14.8.1 Sigma-Tau Group Company Profile

        • 14.8.2 Sigma-Tau Group Liposome Drug Delivery Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Shanghai New Asia

        • 14.9.1 Shanghai New Asia Company Profile

        • 14.9.2 Shanghai New Asia Liposome Drug Delivery Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Luye Pharma

        • 14.10.1 Luye Pharma Company Profile

        • 14.10.2 Luye Pharma Liposome Drug Delivery Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Gilead Sciences

        • 14.11.1 Gilead Sciences Company Profile

        • 14.11.2 Gilead Sciences Liposome Drug Delivery Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Pacira

        • 14.12.1 Pacira Company Profile

        • 14.12.2 Pacira Liposome Drug Delivery Market Performance

        • 14.12.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Liposome Drug Delivery Industry Research Conclusions

    • 15.2 Liposome Drug Delivery Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Liposome Drug Delivery Industry Market Size (2018-2029)

    • Figure China Liposome Drug Delivery Production Volume, Production Value and Growth Rate of Liposomal Doxorubicin (2018-2029)

    • Figure China Liposome Drug Delivery Production Volume, Production Value and Growth Rate of Other Liposomals (2018-2029)

    • Figure China Liposome Drug Delivery Production Volume, Production Value and Growth Rate of Liposomal Paclitaxel (2018-2029)

    • Figure China Liposome Drug Delivery Production Volume, Production Value and Growth Rate of Liposomal Bupivacaine (2018-2029)

    • Figure China Liposome Drug Delivery Production Volume, Production Value and Growth Rate of Liposomal Amphoteracin B (2018-2029)

    • Figure China Liposome Drug Delivery Sales Volume, Sales Value and Growth Rate of Fungal Infection Therapy (2018-2029)

    • Figure China Liposome Drug Delivery Sales Volume, Sales Value and Growth Rate of Cancer and Tumor Therapy (2018-2029)

    • Figure China Liposome Drug Delivery Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure Central China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure South China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure East China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Liposome Drug Delivery Market Size and Growth Rate from 2018-2029

    • Figure Liposome Drug Delivery Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Liposome Drug Delivery Market Share by Type in 2018

    • Figure China Liposome Drug Delivery Market Share by Type in 2023

    • Figure China Liposome Drug Delivery Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Liposome Drug Delivery Production Volume and Growth Rate of Liposomal Doxorubicin (2018-2023)

    • Figure China Liposome Drug Delivery Production Volume and Growth Rate of Other Liposomals (2018-2023)

    • Figure China Liposome Drug Delivery Production Volume and Growth Rate of Liposomal Paclitaxel (2018-2023)

    • Figure China Liposome Drug Delivery Production Volume and Growth Rate of Liposomal Bupivacaine (2018-2023)

    • Figure China Liposome Drug Delivery Production Volume and Growth Rate of Liposomal Amphoteracin B (2018-2023)

    • Figure China Liposome Drug Delivery Market Share by Application in 2018

    • Figure China Liposome Drug Delivery Market Share by Application in 2023

    • Figure China Liposome Drug Delivery Total Market Size and Growth Rate from Consumption End

    • Figure China Liposome Drug Delivery Market Size and Growth Rate of Fungal Infection Therapy (2018-2023)

    • Figure China Liposome Drug Delivery Market Size and Growth Rate of Cancer and Tumor Therapy (2018-2023)

    • Figure China Liposome Drug Delivery Market Size and Growth Rate of Others (2018-2023)

    • Table China Liposome Drug Delivery Production Volume by Region (2018-2023)

    • Table China Liposome Drug Delivery Production Volume Share by Region (2018-2023)

    • Figure China Liposome Drug Delivery Production Volume Share by Region (2018-2023)

    • Table China Liposome Drug Delivery Production Value by Region (2018-2023)

    • Table China Liposome Drug Delivery Production Value Share by Region (2018-2023)

    • Figure China Liposome Drug Delivery Production Value Share by Region (2018-2023)

    • Table China Liposome Drug Delivery Sales Volume by Region (2018-2023)

    • Table China Liposome Drug Delivery Sales Volume Share by Region (2018-2023)

    • Figure China Liposome Drug Delivery Sales Volume Share by Region (2018-2023)

    • Table China Liposome Drug Delivery Sales Value by Region (2018-2023)

    • Table China Liposome Drug Delivery Sales Value Share by Region (2018-2023)

    • Figure China Liposome Drug Delivery Sales Value Share by Region (2018-2023)

    • Table North China Liposome Drug Delivery Production Volume by Type (2018-2023)

    • Table North China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure North China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Table North China Liposome Drug Delivery Sales Volume by Application (2018-2023)

    • Table North China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure North China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table Central China Liposome Drug Delivery Production Volume by Type (2018-2023)

    • Table Central China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure Central China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Table Central China Liposome Drug Delivery Sales Volume by Application (2018-2023)

    • Table Central China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure Central China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table South China Liposome Drug Delivery Production Volume by Type (2018-2023)

    • Table South China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure South China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Table South China Liposome Drug Delivery Sales Volume by Application (2018-2023)

    • Table South China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure South China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table East China Liposome Drug Delivery Production Volume by Type (2018-2023)

    • Table East China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure East China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Table East China Liposome Drug Delivery Sales Volume by Application (2018-2023)

    • Table East China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure East China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table Northeast China Liposome Drug Delivery Production Volume by Type (2018-2023)

    • Table Northeast China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure Northeast China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Table Northeast China Liposome Drug Delivery Sales Volume by Application (2018-2023)

    • Table Northeast China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table Southwest China Liposome Drug Delivery Production Volume by Type (2018-2023)

    • Table Southwest China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure Southwest China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Table Southwest China Liposome Drug Delivery Sales Volume by Application (2018-2023)

    • Table Southwest China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table Northwest China Liposome Drug Delivery Production Volume by Type (2018-2023)

    • Table Northwest China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Figure Northwest China Liposome Drug Delivery Production Volume Share by Type (2018-2023)

    • Table Northwest China Liposome Drug Delivery Sales Volume by Application (2018-2023)

    • Table Northwest China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Liposome Drug Delivery Sales Volume Share by Application (2018-2023)

    • Table Spectrum Pharmaceuticals Company Profile

    • Table Spectrum Pharmaceuticals Liposome Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Company Profile

    • Table Teva Pharmaceutical Liposome Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Sun Pharmaceutical Company Profile

    • Table Sun Pharmaceutical Liposome Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Kingond Pharm Company Profile

    • Table Kingond Pharm Liposome Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table CSPC Company Profile

    • Table CSPC Liposome Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Fudan-Zhangjiang Company Profile

    • Table Fudan-Zhangjiang Liposome Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Johnson and Johnson Company Profile

    • Table Johnson and Johnson Liposome Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Sigma-Tau Group Company Profile

    • Table Sigma-Tau Group Liposome Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Shanghai New Asia Company Profile

    • Table Shanghai New Asia Liposome Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Luye Pharma Company Profile

    • Table Luye Pharma Liposome Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences Company Profile

    • Table Gilead Sciences Liposome Drug Delivery Revenue, Price and Gross (2018-2023)

    • Table Pacira Company Profile

    • Table Pacira Liposome Drug Delivery Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US